Mast Therapeutics Provides Clinical Developments Update; Range-Bound Trading A Mid-Term Plausibility
September 27, 2016 at 10:57 AM EDT
On Monday, Mast Therapeutics Inc (NYSE: MSTX) provided an update on its business strategy and the clinical development of its product ...